Derlin-2 Activators

Derlin-2 activators are an array of chemical compounds that indirectly bolster the activity of Derlin-2 by modulating various stress pathways within the endoplasmic reticulum (ER). MG-132, a proteasome inhibitor, and Kifunensine, a mannosidase inhibitor, both cause an accumulation of proteins that require degradation, thereby increasing the functional demand on the ERAD pathway, in which Derlin-2 is a critical component. Tunicamycin, by inhibiting N-linked glycosylation, and Thapsigargin, a SERCA pump inhibitor, induce ER stress, which could amplify the need for ERAD activity and, hence, Derlin-2's role. Brefeldin A disrupts ER-Golgi transport, further contributing to ER stress and possibly enhancing Derlin-2 activity by upregulating the ERAD pathway. Additionally, ERAD pathway inhibitors such as Eeyarestatin I, DBeQ, and NMS-873, by interfering with components like the p97 ATPase, lead to increased levels of substrates for Derlin-2, escalating its functional activity.

Further adding to this ensemble are compounds that impact the ubiquitin-proteasome system and stress response elements tied to Derlin-2's operational milieu. MLN4924 inhibits the NEDD8-activating enzyme, leading to protein accumulation in the ER, while Radicicol targets HSP90, causing client protein destabilization and subsequent ER stress. Salubrinal and Guanabenz, both targeting the phosphorylation state of eIF2α, enhance ER stress responses, thereby increasing the activity of the ERAD pathway, of which Derlin-2 is an integral part. These diverse yet interconnected chemical modulators collectively intensify the functional activity of Derlin-2 by heightening the ERAD pathway's demand, spotlighting the protein's pivotal role in maintaining cellular proteostasis.